$19.27
-0.08-0.41%
At Close: -
$18.90
-0.37-1.91%
After Hours: 2:35 PM EDT
15 minutes delayed
Crescent Capital BDC
CCAPNASDAQ
Crescent Capital BDC (NASDAQ:CCAP) Stock, Analyst Ratings, Price Targets, Predictions
Crescent Capital BDC Inc has a consensus price target of $15.75, established from looking at the 17 latest analyst ratings. The last 3 analyst ratings were released from Keefe, Bruyette & Woods, Wells Fargo, and Raymond James on May 23, 2024, May 13, 2024, and May 10, 2024. With an average price target of $18.67 between Keefe, Bruyette & Woods, Wells Fargo, and Raymond James, there's an implied -1.25% downside for Crescent Capital BDC Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Keefe, Bruyette & Woods
Wells Fargo
Raymond James
Oppenheimer
B of A Securities
1calculated from analyst ratings
Analyst Ratings for Crescent Capital BDC
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/23/2024 | Buy Now | 0.52% | Keefe, Bruyette & Woods | Ryan Lynch | $18.5 → $19 | Maintains | Outperform | Get Alert |
| 05/13/2024 | Buy Now | -4.77% | Wells Fargo | Finian O'Shea | $16.5 → $18 | Maintains | Equal-Weight | Get Alert |
| 05/10/2024 | Buy Now | 0.52% | Raymond James | Robert Dodd | $18 → $19 | Maintains | Outperform | Get Alert |
| 02/23/2024 | Buy Now | 0.52% | Oppenheimer | Mitchel Penn | $18 → $19 | Maintains | Outperform | Get Alert |
| 01/29/2024 | Buy Now | -12.71% | Wells Fargo | Finian O'Shea | $16 → $16.5 | Maintains | Equal-Weight | Get Alert |
| 11/13/2023 | Buy Now | -15.35% | Wells Fargo | Finian O'Shea | $16.5 → $16 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 05/16/2023 | Buy Now | -4.77% | Oppenheimer | Mitchel Penn | → $18 | Reiterates | Outperform → Outperform | Get Alert |
| 04/11/2023 | Buy Now | -4.77% | Keefe, Bruyette & Woods | Ryan Lynch | → $18 | Initiates | → Outperform | Get Alert |
| 02/24/2023 | Buy Now | -4.77% | Oppenheimer | Mitchel Penn | $19 → $18 | Maintains | Outperform | Get Alert |
| 10/05/2022 | Buy Now | -4.77% | Raymond James | Robert Dodd | $20.5 → $18 | Maintains | Outperform | Get Alert |
| 08/12/2022 | Buy Now | 0.52% | Oppenheimer | Mitchel Penn | $20 → $19 | Upgrade | Perform → Outperform | Get Alert |
| 08/12/2022 | Buy Now | 8.45% | Raymond James | Robert Dodd | $21 → $20.5 | Maintains | Outperform | Get Alert |
| 05/11/2022 | Buy Now | -4.77% | Wells Fargo | Finian O'Shea | $18.5 → $18 | Maintains | Overweight | Get Alert |
| 04/25/2022 | Buy Now | -2.13% | Wells Fargo | Finian O'Shea | $19.5 → $18.5 | Maintains | Overweight | Get Alert |
| 01/31/2022 | Buy Now | 3.16% | B of A Securities | Derek Hewett | → $19.5 | Initiates | → Buy | Get Alert |
| 11/12/2021 | Buy Now | 13.74% | Raymond James | Robert Dodd | — | Maintains | Outperform | Get Alert |
| 07/16/2021 | Buy Now | — | Oppenheimer | — | — | Initiates | → Perform | Get Alert |
FAQ
What is the target price for Crescent Capital BDC (CCAP) stock?
The latest price target for Crescent Capital BDC (NASDAQ:CCAP) was reported by Keefe, Bruyette & Woods on May 23, 2024. The analyst firm set a price target for $19.00 expecting CCAP to rise to within 12 months (a possible 0.52% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Crescent Capital BDC (CCAP)?
The latest analyst rating for Crescent Capital BDC (NASDAQ:CCAP) was provided by Keefe, Bruyette & Woods, and Crescent Capital BDC maintained their outperform rating.
When was the last upgrade for Crescent Capital BDC (CCAP)?
The last upgrade for Crescent Capital BDC Inc happened on August 12, 2022 when Oppenheimer raised their price target to $19. Oppenheimer previously had a perform for Crescent Capital BDC Inc.
When was the last downgrade for Crescent Capital BDC (CCAP)?
The last downgrade for Crescent Capital BDC Inc happened on November 13, 2023 when Wells Fargo changed their price target from $16.5 to $16 for Crescent Capital BDC Inc.
When is the next analyst rating going to be posted or updated for Crescent Capital BDC (CCAP)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Crescent Capital BDC, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Crescent Capital BDC was filed on May 23, 2024 so you should expect the next rating to be made available sometime around May 23, 2025.
Is the Analyst Rating Crescent Capital BDC (CCAP) correct?
While ratings are subjective and will change, the latest Crescent Capital BDC (CCAP) rating was a maintained with a price target of $18.50 to $19.00. The current price Crescent Capital BDC (CCAP) is trading at is $18.90, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.